← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2008Last known activity
Feb 20, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06312982CollaboratorPhase 2/Phase 3Feb 20, 2024
- NCT01492556CollaboratorPhase 2Dec 1, 2011
- NCT00656253CollaboratorPhase 2/Phase 3Aug 1, 2008
Details
- Last known activity
- Feb 20, 2024